Atom Therapeutics
OrganisationROR
Trials
Phase 1, Recruiting, 20 people, 26 Jan 2026
Phase 2, Recruiting, 380 people, 28 Aug 2025
Phase 2/3, Terminated, 43 people, 26 Feb 2024
Phase 2/3, Completed, 300 people, 18 Apr 2023
Named in competing interests
Liquid biopsy for early detection of pancreatic ductal adenocarcinoma
Board or leadership role, 16 Sept 2026
Sources: pubmed.ncbi.nlm.nih.gov